Description
This oral abstract session will showcase the highest-scoring abstracts highlighting advances in VT management including use of stellate ganglion phototherapy and stereotactic ablative radiosurgery.
Learning Objectives
- Explain the impact of dantrolene on supression of inducible VT.
- Summarize the impact of stellate ganglion phototherapy on refractory VT.
- Discover novel strategies for VT management.
Session Chair(s)
Piotr Futyma, MD, PhD
Presentation
Daily Application of Stellate Ganglion Phototherapy for Refractory Ventricular Arrhythmias: A Groundbreaking Non-Invasive Treatment Strategy
Presenter(s): Yoshihiro Harano, MD, Yasutoshi Shinoda, Yuichi Hanaki, MD, Yutaro Okidono, Yuki Matsuoka, Yukiya Honda, YUTO IIOKA, MD, Tabito Kino, MD, PhD, Akira Kimata, MD, Kojiro Ogawa, Hiro Yamasaki, MD, Miyako Igarashi, MD, Tomoko Ishizu, Yuki Komatsu, MD, PhD
STAR VT randomized trial comparing stereotactic ablative radiosurgery for recurrent VT with repeated radiofrequency ablation in patients with structural heart disease
Presenter(s): Jana Haskova, Dan Wichterle, MD, PhD, Petr Peichl, MD, PhD, Lukas Knybel, Radek Neuwirth, Otakar Jiravsky, Marek Sramko, Jakub Cvek, Josef Kautzner, MD, PhD
Geometric Characteristics of Ventricular Tachycardia Corridors in Patients with Ischemic Cardiomyopathy
Presenter(s): Lingyu Xu, MD, PhD, Stanislau Hrybouski, Ting-Wei Ernie. Liao, Mirmilad Pourmousavi Khoshknab, MD, David J. Callans, MD, Francis Marchlinski, Walter R. Witschey, Benoit Desjardins, Saman Nazarian, MD, PhD
Cardiac RADIoablation versus repeat catheter Ablation: a pivotal randomized clinical Trial Evaluating safety and efficacy for patients with high-risk refractory Ventricular Tachycardia (RADIATE-VT)
Presenter(s): Konstantinos C. Siontis, MD, Kenneth Merrell, Clifford G. Robinson, Paul C. Zei, MD, PhD, Geoffrey Hugo, PhD, Claire McCann, BENG, MHS, PhD, Ping-Yu Liu, Phillip Cuculich, MD
Ryanodine Receptor-2 (RyR2) Inhibition with Dantrolene Suppresses Inducible VT: Results of a Randomized Controlled Trial in Patients with Structural Heart Disease
Presenter(s): Majd El-Harasis, MD, Zachary Yoneda, MD, MSci, Bibin Varghese, MD, Diane Crawford, Dakota Grauherr, Lili Sun, Fei Ye, Kara Siegrist, Frederic Billings, Bjorn C. Knollmann, MD, PhD, William G. Stevenson, MD, Ben B. Shoemaker, MD
Disclosures
Yoshihiro Harano:
- Nothing Relevant to Disclose
Jana Haskova:
- Nothing Relevant to Disclose
Lingyu Xu:
- Nothing Relevant to Disclose
Konstantinos Siontis:
- Anumana (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- Anumana (Intellectual Property Rights - Co-inventor of AI ECG algorithm (HCM) that is licensed to Anumana)
- EBAMed SA (Honoraria/Speaking/Consulting Fee - Consulting)
- Varian Medical Systems (Research (Contracted Grants for PIs and Named Investigators only) - Research)
- AskBio (Honoraria/Speaking/Consulting Fee - Consulting)
Majd El-Harasis:
- Nothing Relevant to Disclose
To view all Heart Rhythm 2025 Faculty Disclosures, please click
here.
Education Framework
Ventricular Tachyarrhythmias
-- Ventricular Tachycardia (VT) - Catheter Ablation
-- 184. Know the indications, contraindications, and complications associated with catheter ablation of ventricular arrhythmias, including endocardial and epicardial ablation, including during pregnancy.